P

Insulet Corp

PODD

197.390
USD
2.95
(1.52%)
Market Open
Volume
4,364
EPS
0
Div Yield
0
P/E
42
Market Cap
16,462,414,019
Related Instruments
ABT
4.220
(3.98%)
110.150 USD
BSX
1.315
(1.78%)
75.170 USD
DXCM
2.510
(3.70%)
70.340 USD
EW
-1.220
(-1.94%)
61.830 USD
ISRG
6.98
(1.57%)
451.27 USD
MDT
0.160
(0.20%)
80.470 USD
P
PODD
2.950
(1.52%)
197.390 USD
TMO
9.03
(1.47%)
621.78 USD
T
TNDM
-1.800
(-4.87%)
35.170 USD
News

Title: Insulet Corp

Sector: Healthcare
Industry: Medical Devices
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.